Literature DB >> 34850927

One view of the next decade of research on behavioral and biobehavioral approaches to cancer prevention and control: intervention optimization.

Linda M Collins1, Jillian C Strayhorn2, David J Vanness3.   

Abstract

As a new decade begins, we propose that the time is right to reexamine current methods and procedures and look for opportunities to accelerate progress in cancer prevention and control. In this article we offer our view of the next decade of research on behavioral and biobehavioral interventions for cancer prevention and control. We begin by discussing and questioning several implicit conventions. We then briefly introduce an alternative research framework: the multiphase optimization strategy (MOST). MOST, a principled framework for intervention development, optimization, and evaluation, stresses not only intervention effectiveness, but also intervention affordability, scalability, and efficiency. We review some current limitations of MOST along with future directions for methodological work in this area, and suggest some changes in the scientific environment we believe would permit wider adoption of intervention optimization. We propose that wider adoption of intervention optimization would have a positive impact on development and successful implementation of interventions for cancer prevention and control and on intervention science more broadly, including accumulation of a coherent base of knowledge about what works and what does not; establishment of an empirical basis for adaptation of interventions to different settings with different levels and types of resources; and, in the long run, acceleration of progress from Stage 0 to Stage V in the National Institutes of Health Model of Stages of Intervention Development. © Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 34850927      PMCID: PMC8634530          DOI: 10.1093/tbm/ibab087

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  30 in total

1.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.

Authors:  K Claxton
Journal:  J Health Econ       Date:  1999-06       Impact factor: 3.883

2.  Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention.

Authors:  J B McClure; H Derry; K R Riggs; E W Westbrook; J St John; S M Shortreed; A Bogart; L C An
Journal:  Contemp Clin Trials       Date:  2012-07-04       Impact factor: 2.226

3.  A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.

Authors:  Megan E Piper; Jessica W Cook; Tanya R Schlam; Douglas E Jorenby; Stevens S Smith; Linda M Collins; Robin Mermelstein; David Fraser; Michael C Fiore; Timothy B Baker
Journal:  Ann Behav Med       Date:  2018-09-13

4.  A case for Bayesianism in clinical trials.

Authors:  D A Berry
Journal:  Stat Med       Date:  1993-08       Impact factor: 2.373

5.  A Nursing Intervention for Reducing Symptom Burden During Chemotherapy
.

Authors:  Annemarie Coolbrandt; Hans Wildiers; Annouschka Laenen; Bert Aertgeerts; Bernadette Dierckx de Casterlé; Theo van Achterberg; Koen Milisen
Journal:  Oncol Nurs Forum       Date:  2018-01-01       Impact factor: 2.172

6.  Effects of motivation phase intervention components on quit attempts in smokers unwilling to quit: A factorial experiment.

Authors:  Jessica L Engle; Robin Mermelstein; Timothy B Baker; Stevens S Smith; Tanya R Schlam; Megan E Piper; Douglas E Jorenby; Linda M Collins; Jessica W Cook
Journal:  Drug Alcohol Depend       Date:  2019-02-16       Impact factor: 4.492

7.  Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.

Authors:  Yanan Wu; Yingru Liang; Qin Zhou; Huazhang Liu; Guozhen Lin; Wenfeng Cai; Yan Li; Jing Gu
Journal:  Cancer       Date:  2019-03-02       Impact factor: 6.860

8.  A Factorial Experiment to Optimize Remotely Delivered Behavioral Treatment for Obesity: Results of the Opt-IN Study.

Authors:  Bonnie Spring; Angela F Pfammatter; Sara H Marchese; Tammy Stump; Christine Pellegrini; H Gene McFadden; Donald Hedeker; Juned Siddique; Neil Jordan; Linda M Collins
Journal:  Obesity (Silver Spring)       Date:  2020-07-12       Impact factor: 5.002

9.  Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment.

Authors:  Jessica W Cook; Linda M Collins; Michael C Fiore; Stevens S Smith; David Fraser; Daniel M Bolt; Timothy B Baker; Megan E Piper; Tanya R Schlam; Douglas Jorenby; Wei-Yin Loh; Robin Mermelstein
Journal:  Addiction       Date:  2015-11-19       Impact factor: 6.526

10.  Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment.

Authors:  Tanya R Schlam; Michael C Fiore; Stevens S Smith; David Fraser; Daniel M Bolt; Linda M Collins; Robin Mermelstein; Megan E Piper; Jessica W Cook; Douglas E Jorenby; Wei-Yin Loh; Timothy B Baker
Journal:  Addiction       Date:  2015-11-19       Impact factor: 6.526

View more
  3 in total

1.  Behavioral medicine, cancer control, and NCI: reflections on a fruitful past and auspicious future.

Authors:  William M P Klein
Journal:  Transl Behav Med       Date:  2021-11-30       Impact factor: 3.046

2.  Developing Mobile Health Interventions With Implementation in Mind: Application of the Multiphase Optimization Strategy (MOST) Preparation Phase to Diabetes Prevention Programming.

Authors:  Megan MacPherson; Kohle Merry; Sean Locke; Mary Jung
Journal:  JMIR Form Res       Date:  2022-04-26

Review 3.  mHealth Interventions to Promote a Healthy Diet and Physical Activity among Cancer Survivors: A Systematic Review of Randomized Controlled Trials.

Authors:  Lufan Wang; Crystal S Langlais; Stacey A Kenfield; June M Chan; Rebecca E Graff; Isabel E Allen; Chloe E Atreya; Erin L Van Blarigan
Journal:  Cancers (Basel)       Date:  2022-08-06       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.